期刊文献+

白细胞介素13基因启动子区多态性与特发性肺纤维化的关系 被引量:2

The study of interleukln-13 gene promoter polymorphism in patients with idiopathic pulmonary fibrosis
下载PDF
导出
摘要 目的探讨白细胞介素13(IL-13)基因启动子区-1112(C/T)位点基因多态性与特发性肺纤维化(IPF)的相关性。方法研究组IPF患者70例,根据肺功能分为3个亚组,以A(弥散功能轻度下降,22例)、B(弥散功能中度下降,20例)、C(弥散功能重度下降,28例)组表示,80例健康体检者作为对照组。外周血提取基因组DNA,采用聚合酶链反应-限制性片段长度多态性(PCR—RFLP)检测IL-13基因启动子区-1112(C/T)位点的基因多态性。结果研究组IL-13基因启动子区-1112(C/T)位点的基因多态性分布为CC纯合子28例(40.O%),TT纯合子6例(8.6%),CT杂合子36例(51.4%);对照组CC纯合子30例(37.5%),TT纯合子11例(13.8%),CT杂合子39例(48.8%),-1112(C/T)位点等位基因C、T在两组间分布及三种基因型之间构成比比较差异无统计学意义(P〉0.05)。A组CT和TT基因型共9例(40.9%),B组CT和TT基因型共10例(50.0%),C组CT和TT基因型共23例(82.1%),三组间比较差异有统计学意义(P均〈0.05)。结论IL—13基因启动子区-1112(C/T)位点基因多态性与IPF的发病无关,但与其肺弥散功能的损害程度有关。 Objective To investigate the potential correlation of interleukin- 13 (IL- 13 )gene promoter -1112(C/T)polymorphism with idiopathic pulmonary fibrosis(IPF). Methods According to the dif- fusion for carbon monoxide (DLCO) or diffusion coefficient (DLCO/VA), 70 patients with IPF (investigation group) divided into three groups (group A, group B and group C)and gO healthy controls (control group ) were investigated. The IL-13 gene promoter-1112 (C/T)polymorphism was genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. The pulmonary diffusion function was measured by DLCO and DLCONA. Results The IL-13 gene promoter -1112(C/T)polymorphism frequency of the homozygous CC ,homozygous TT and heterozygous CT was 40.0% (28 cases), 8.6% (6 cases ) and 51.4% (36 cases)in investigation group. The frequency of the homozygous CC, homozygous TT and bet- erozygous CT was 37.5% (30 cases), 13.8% ( 11 cases) and 48.8%(39 cases)in control group. There were no significant differences in the distribution of the three genotypes between the two groups (P 〉 0.05 ). The frequency of the heterozygous CT and homozygous TT was 40.9% (9/22)in group A, 50.0% (10/20) in group B and 82.1% (23/28)in group C..There were significant differences in the distribution of the three genotypes among group A, B and C (P 〈 0.05 ). Conclusion IL- 13 gene promoter - 1112 (C/T)polymorphism may not be involved in the development of the IPF and may be related to pulmonary diffusion function.
出处 《中国医师进修杂志(内科版)》 2008年第8期12-15,共4页 Chinese Journal of Postgraduates of Medicine
基金 江苏省社会发展项目(BS2001020) 江苏大学临床医学科技发展基金(JLY20050087)
关键词 肺纤维化 白细胞介素13 呼吸功能试验 基因多态性 Pulmonary fibrosis Interleukin-13 Respiratory function tests Gene polymorphism
  • 相关文献

参考文献10

  • 1de Waal Malefyt R ,Figdor CG, Huijkbens R,et al. Effects of IL-13 on phenotype, cytokine production,and cytotoxic function of human monoeytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol, 1993,151 ( 11 ):6370-6381.
  • 2Kaviratne M, Hesse M, Leusink M,et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J Immunol, 2004,173 ( 6 ):4020-4029.
  • 3Heinzmann A,Mao XQ, Akainua M,et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet,2000,9 (4):549-559.
  • 4Jakubzick C, Choi ES, Kunkel SL,et al. Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia. J Clin Pathol, 2004,57(5):477-486.
  • 5Jakubzick C, Choi ES, Joshi BH, et al. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol, 2003,171 ( 5): 2684-2693.
  • 6Taniguchi H, Katoh S, Kadota J ,et al. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bron-choalveolar lavage fluid in interstitial lung disease. Eur Respir J, 2000,16( 5 ):959-964.
  • 7Fujimoto K,Kubo K, Yamaguchi S,et al. Eosinophil activation in patients with pulmonary fiborsis.Chest, 1995.108( 1 ):48-54.
  • 8Graves PE , Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immumol, 2000,105( 3 ):506-513.
  • 9温华,康健,李振华,侯显明,于润江.特发性肺纤维化患者嗜酸粒细胞与肺功能相关性的研究[J].中华结核和呼吸杂志,2004,27(10):698-699. 被引量:1
  • 10Wang M, Xing ZM, Lu C,et al. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet, 2003, 113(5 ):387-390.

二级参考文献9

  • 1Taniguchi H, Katoh S, Kadota J, et al. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease. Eur Respir J, 2000, 16:959-964.
  • 2Fujimoto K, Kubo K, Yamaguchi S, et al. Eosinophil activation in patients with pulmonary fibrosis. Chest, 1995, 108:48-54.
  • 3Hallgren R, Bjermer L, Lundgren R, et al. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis, 1989, 139:373-377.
  • 4Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis, 1987, 135:696-704.
  • 5Inage M, Nakamura H, Kato S, et al. Levels of cytokeratine 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis. Respir Med, 2000, 94:155-160.
  • 6Pincus SH, Ramesh KS, Wyler DJ. Eosinophils stimulate fibroblast DNA synthesis. Blood,1987,70:572-574
  • 7Taylor ML, Noble PW, White B, et al. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease. Clin Immunol, 2000, 94:33-41.
  • 8特发性肺(间质)纤维化诊断和治疗指南(草案)[J].中华结核和呼吸杂志,2002,25(7):387-389. 被引量:631
  • 9支气管肺泡灌洗液细胞学检测技术规范(草案)[J].中华结核和呼吸杂志,2002,25(7):390-391. 被引量:200

同被引文献25

  • 1黄登鹏,杨鸣,彭卫平,陈小设,陈仲清.胸腺肽α_1对危重病人气管切开肺部感染的防治作用[J].南方医科大学学报,2006,26(1):128-129. 被引量:10
  • 2李银生,牛建昭,王继峰,周刚,杨美娟.姜黄素对肺纤维化大鼠肺组织胶原沉积及转化生长因子β_1表达的影响[J].中华中医药学刊,2007,25(1):55-57. 被引量:26
  • 3陈骥,梁标.特发性肺纤维化治疗进展[J].国际呼吸杂志,2007,27(4):287-291. 被引量:6
  • 4Kalayarasan S, Sriram N, Soumyakrishnan S, et al. l)iallylsulfidc attenuates excessive eallagen production and apnptosis in u rat model of bleomycin induced pulmonary fibrosis through the in- volvement of protease activated receptor-2. Tnxicol Appl Pharna- col,2013,5(5) : S0041-008X( 13)00176-2.
  • 5Patsenker E, Schneider V, Ledermann M, et al. Potent antifibrot- ic activity of mTOR inhibitors sirolimus and evemlimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepato1,2011,55 ( 2 ) :388-398.
  • 6Gao J, Huang Y, Li P, et al. Antifibrosis effects of total gluco- sides of Danggui-Buxue-Tang in a rat model of bleomychl-induced pulmonary fibrosis. J Etimophammcol, 2011,136 ( 1 ) :21-26.
  • 7Yoshizaki A, Yanaba K, Yoshizaki A, et al. Treatment with rapmn.v- tin prevents fibrosis in tight-skin mid bleomytqn-indueed mouse mod- els of systemic sclertmis. Arthritis Rheum,2010,62(8 ) :2476-2487.
  • 8Ozdemir BH, Ozdemir AA, Erdal R, et al. Rapamycin prevents interstitial fibrosis in renal allografts through decreasing angiogene- sis and inflammation. Transplant Proc,2011,43 ( 2 ) :524-526.
  • 9Bridle KR, Popa C, Morgan MI., et al. Rapamycin inhibits hepat- ic fibrosis in rals by attenuating multiple profibrogeni, palhways. Liver Transp1,2009,15 ( 10 ) : 1315-1324.
  • 10Korfhagen TR, l-e Cras TD, Davidson CR, et al. Rapamycin prevents transforming growth factor-alpha-induced imhnonary fi- brosis. Am J Respir Cell Mol Biol, 2009,41 (5) :562-572.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部